Psychedelic stocks: focus on their cash
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Jason Najum has https://seekingalpha.com/author/jason-najum?source=cip_podcast:psychedelic_stocks_focus_on_their_cash the psychedelic space for a long time and contextualizes recent https://seekingalpha.com/article/4711635-mindmed-and-other-psychedelic-stocks-brace-for-fdas-decision-on-mdma-therapy?source=ie_podcast:psychedelic_stocks_focus_on_their_cash around the FDA, MDMA, PTSD and Lykos Therapeutics (1:35). Blessing in disguise for Cybin, COMPASS...
mostra di piùRead episode transcripts
Show Notes:
FDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks Unchanged
MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors
ATAI: Enormous Potential Upside But No Clarity Yet
De-Risking Psychedelics: Compass Pathways, Cybin And Atai
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Informazioni
| Autore | Seeking Alpha |
| Organizzazione | Seeking Alpha |
| Sito | seekingalpha.com |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
